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PCR-restriction fragment length polymorphism analysis (PRA) using the novel region of the rpoB gene was
developed for rapid and precise identification of mycobacteria to the species level. A total of 50 mycobacterial
reference strains and 3 related bacterial strains were used to amplify the 360-bp region of rpoB, and the
amplified DNAs were subsequently digested with restriction enzymes such as MspI and HaeIII. The results
from this study clearly show that most of the mycobacterial species were easily differentiated at the species level
by this PRA method. In addition, species with several subtypes, such as Mycobacterium gordonae, M. kansasii,
M. celatum, and M. fortuitum, were also differentiated by this PRA method. Subsequently, an algorithm was
constructed based on the results, and a blinded test was carried out with more than 260 clinical isolates that
had been identified on the basis of conventional tests. Comparison of these two sets of results clearly indicates
that this new PRA method based on the rpoB gene is more simple, more rapid, and more accurate than
conventional procedures for differentiating mycobacterial species.
Since the early 1980s there has been an increase in disease
caused by organisms called nontuberculous mycobacteria
(NTM), which is the generic name for mycobacteria other than
Mycobacterium tuberculosis and M. leprae. They affect both
immune-competent and immune-compromised persons, and
patients with the human immunodeficiency virus are known to
be especially vulnerable. The NTM most frequently involved in
disease cases are M. avium complex, M. kansasii, M. chelonae,
M. abscessus, M. xenopi, M. malmoense, M. scrofulaceum, M.
marinum, M. ulcerans, and M. haemophilum (28). Clinical di-
agnosis and treatment of NTM infections are an increasingly
frequent challenge to clinicians.
Currently, identification of clinical isolates of mycobacteria
to the species level is primarily based on cultural characteristics
and biochemical tests. These conventional tests take several
weeks, and they sometimes fail to provide precise identifica-
tion. The procedures for these tests are complex and laborious,
and they are usually impeded by the slow growth of mycobac-
teria in clinical laboratories. Additional methods, such as high-
performance liquid chromatography, gas-liquid chromatogra-
phy, and thin-layer chromatography (5, 21, 36) as well as DNA
sequence analysis (3, 4, 15–17, 19, 26, 31, 32), can differentiate
mycobacteria to the species level, but these techniques are
labor intensive and difficult to perform for routine use in clin-
ical laboratories. Recently developed molecular techniques us-
ing amplified DNA and probe hybridization (6, 8–10, 18, 20,
23) are also useful for direct and rapid identification of NTM
species, but their overall cost is high. In addition, currently
available kits are limited to the identification of a few species.
In contrast to the above-mentioned techniques, PCR-restric-
tion fragment length polymorphism analysis (PRA) offers an
easy, rapid, and inexpensive way to identify several mycobac-
terial species in a single experiment. PRA techniques have
been developed to target mycobacterial genes which are
present in all mycobacteria, such as hsp65 (7, 11, 25, 29, 30, 34,
35), the 16S rRNA gene (2, 14, 37), and dnaJ (33). However,
the previous PRA techniques are still cumbersome since they
require several enzyme digestions for species identification,
and the results are not easy to interpret for species identifica-
tion due to the limited size differences of DNA fragments after
digestion.
Therefore, the aim of this study was to develop a new PRA
method that is easier to perform and more precise for myco-
bacterial species identification than currently available PRA
techniques. We chose as a target for our new PRA method
rpoB, a conserved gene that encodes the b subunit of RNA
polymerase. The information-rich nature of the rpoB gene has
been recently used in differentiation of mycobacteria by DNA
hybridization array (10) and by DNA sequence (16) analyses.
However, the rpoB region used in these previous studies has
limited sequence differences, making it difficult to generate
diverse restriction fragment length polymorphism (RFLP) pro-
files that can be used for species identification of mycobacteria.
In the present study, we extended the genetic knowledge of the
rpoB gene to a region that is relatively polymorphic and thus
suitable for PRA. In addition, this region of the rpoB gene is
flanked by conserved sequences, making it suitable for PCR
amplification with the same set of PCR primers.
A 360-bp region of rpoB was amplified from the DNA of 50
mycobacterial reference strains, representing 44 species and a
total of 260 clinical isolates, to evaluate this method for my-
cobacterial species identification. The results of this study show
that this novel PRA method based on the rpoB genes of my-
cobacteria generates clear and distinctive results for easy,
rapid, and precise identification of mycobacterial species.
MATERIALS AND METHODS
Mycobacterial samples. A total of 50 mycobacterial reference strains repre-
senting 44 mycobacterial species and 3 related species which belong to 2 different
genera (Table 1) were used to develop the new PRA method in this study.
Among them, 40 mycobacterial strains and 3 related species were obtained from
the Korean Institute of Tuberculosis (KIT), the Korean National Tuberculosis
Association in Seoul. Four species were obtained from the Korean Collection for
Type Cultures at the Korean Research Institute of Bioscience and Biotechnology
* Corresponding author. Mailing address: Korean Institute of Tu-
berculosis, 14 Woomyun-dong, Seocho-Gu, Seoul 137-140, Korea.
Phone: 82-2-575-1547. Fax: 82-2-573-1914. E-mail: sjkim@knta.or.kr.
2966
(KRIBB), and M. abscessus, which was recently separated from M. chelonae as an
independent new species, was obtained from the Department of Clinical Pathol-
ogy at Yonsei University Medical College. Five subtypes of M. kansasii were
generously given by V. Vincent of the Laboratoire de Re´fe´rence des Mycobac-
te´ries, Institut Pasteur, Paris, France.
Clinical isolates subjected to PRA for evaluation of the new method were
obtained from KIT. All clinical isolates used in this study were identified on the
basis of conventional techniques that included microbiological characteristics
and biochemical tests. In some cases, strains were subjected to the conventional
PRA method, based on the hsp65 gene (7, 35), to aid in their precise identifi-
cation.
DNA preparation. To prepare a DNA sample for PCR amplification, a loopful
of a bacterial colony was taken from a Lowenstein-Jensen medium culture and
resuspended in 400 ml of distilled water in a screw-cap microcentrifuge tube. The
sample was then boiled for 5 min prior to being centrifuged for 5 min to settle
cell debris, and about 10 ml of supernatant, containing the genomic DNA, was
used for subsequent PCR amplification.
PCR amplification. Amplification of the region of interest in rpoB with a
primer set consisting of 59-TCAAGGAGAAGCGCTACGA-39 (RPO59) and
59-GGATGTTGATCAGGGTCTGC-39 (RPO39) resulted in 360-bp PCR prod-
ucts (bases 902 to 1261 and codons 302 to 420, based on the sequence of the rpoB
gene of M. tuberculosis [GenBank accession no. P47766]). The primer sequences
were selected from the region of the rpoB gene which have been previously
identified from M. tuberculosis, M. leprae, and M. smegmatis (12, 13, 22). The
primers amplified the region between the first variable region (V1) and second
conserved region (C2) based on the genetic information for the rpoB gene of
Escherichia coli. As a result, the PCR products included 171 bp of variable region
and 189 bp of conserved region. The variable region was amplified in this
experiment based on the theory that the polymorphic nature of this region might
help in the clear distinction of each mycobacterial species by the new PRA
method. The RPO59 primer was derived from relatively conserved sequences
found in the variable region of rpoB.
PCR was carried out in a final volume of 50 ml consisting of 10 ml of DNA
supernatant containing approximately 10 ng of genomic DNA, 10 pmol of each
primer, 2 mM MgCl2, 200 mM deoxynucleoside triphosphates, and 1 U of
DyNAzyme II DNA polymerase (FINNZYMESY, Espoo, Finland). DNA sam-
ples were first denatured completely by incubation at 94°C for 5 min before the
amplification cycle; then DNA was amplified by subjecting it to 35 cycles of (i)
denaturation at 94°C for 1 min, (ii) primer annealing at 58°C for 1 min, and (iii)
elongation at 72°C for 1 min, using a Thermocycler (model 9600, Perkin-Elmer).
After the last amplification cycle, the samples were incubated further at 72°C for
7 min for complete elongation of the final PCR products. Positive and negative
controls were always included in each PCR. The positive control was the PCR
mixture with DNA of the reference strain, M. bovis, and the negative control was
the PCR mixture without any DNA. After the PCR, the amplification results
were visualized by performing 1.5% agarose gel electrophoresis and ethidium
bromide staining.
RFLP. After successful amplification of the 360-bp PCR products was con-
firmed, the PCR products were subjected to restriction enzyme digestion. Most
of the time, 10 to 16 ml of PCR product (approximately 1 to 1.5 mg of DNA) was
digested in a 20-ml reaction volume containing 5 U of MspI (Boehringer Mann-
heim Biochemicals, Mannheim, Germany) and 2 ml of the 103 reaction buffer
supplied by manufacturer. Similarly, 10 to 16 ml of PCR product was digested in
a 20-ml reaction volume containing 5 U of HaeIII enzyme (Takara Shuzo Co.,
Ltd., Shiga, Japan) and the corresponding enzyme buffer. After 2 h of incubation
at 37°C, 4 ml of gel loading buffer (0.25% bromophenol blue, 40% sucrose in
water) was added, and the samples were loaded onto a 4% Metaphore agarose
gel (FMC BioProducts, Rockland, Maine). Then, enzyme-digested fragments
were visualized under UV light after ethidium bromide staining.
For the interpretation of the PRA profile generated by each species, a 50-bp
ladder DNA size marker (Boehringer Mannheim) and the PRA profile of M.
bovis, which generates restriction fragments of about 175, 80, 60, and 40 bp, were
used as internal size markers. Using these markers, the sizes of the restricted
fragments of each species were determined, and an algorithm was constructed
based on this information.
RESULTS
To develop a more rapid and precise yet simple and easy-
to-use PRA method for mycobacterial species identification,
we chose one of the more highly conserved genes, rpoB. Since
the genetic information for the rpoB genes of some mycobac-
teria is available, sequences were aligned and searched for
regions suitable for PRA. As a result, a set of PCR primers was
selected to amplify a 360-bp sequence of rpoB which contains
a polymorphic region flanked by conserved regions.
A total of 50 mycobacterial reference strains and 3 related
bacterial strains that belong to the same class as mycobacteria
(Actinomycetes) were used to amplify the 360-bp region of the
rpoB gene (Table 1). The results showed that a conserved rpoB
gene present in all mycobacteria and in some other bacteria,
such as Nocardia and Rhodococcus species, was amplified. Sub-
sequently, PCR products were subjected to two sets of restric-
tion enzyme digestion, with MspI and HaeIII being used indi-
vidually. These two enzymes were selected on the basis of
sequence information for the rpoB genes of M. tuberculosis, M.
leprae, and M. smegmatis (12, 13, 22). Based on this informa-
tion, PCR products were subsequently subjected to RFLP
analysis (Fig. 1). In short, this analysis showed that the RFLP
profiles of PCR products from each mycobacterial species
were distinctive. M. kansasii can be easily differentiated from
M. gastri, which has much in common with nonpigmented vari-
ants of M. kansasii. In addition, M. abscessus, which had been
classified as a subgroup of M. chelonae and was not easily
differentiated from it by conventional biochemical tests, was
also differentiated from the latter. Furthermore, for some spe-
TABLE 1. Bacterial strains used in this study
Species Strain Source
M. abscessus Pettenkofer Institute YUMCa
M. africanum ATCC 25420 KIT
M. arcinogenes ATCC 35753 KIT
M. asiaticum ATCC 25276 KIT
M. aurum ATCC 23366 KIT
M. austroafricanum ATCC 33464 KRIBB
M. avium ATCC 25291 KIT
M. bovis ATCC 19210 KIT
M. bovis BCG French strain 1173P2 KIT
M. celatum type I/II ATCC 51130/ATCC 51131 KIT
M. chelonae ATCC 35749 KIT
M. chitae ATCC 19627 KIT
M. fallax ATCC 35219 KIT
M. fortuitum type I/II ATCC 6841/ATCC 49404 KIT
M. gallinarum ATCC 19710 KRIBB
M. gastri ATCC 15754 KIT
M. genavense ATCC 51233 KIT
M. gilvum ATCC 43909 KIT
M. gordonae ATCC 14470 KIT
M. haemophilum ATCC 29548 KIT
M. intracellulare ATCC 13950 KIT
M. interjectum ATCC 51457 KIT
M. intermedium ATCC 51848 KIT
M. kansasii type I-V Pasteur Institute
M. malmoense ATCC 29571 KIT
M. marinum ATCC 927 KIT
M. moriokaense ATCC 43059 KRIBB
M. mucogenicum ATCC 49650 KIT
M. neoaurum ATCC 25795 KIT
M. nonchromogenicum ATCC 19530 KIT
M. parafortuitum ATCC 19686 KIT
M. peregrinum ATCC 14467 KIT
M. phlei ATCC 11758 KIT
M. pulveris ATCC 35154 KRIBB
M. scrofulaceum ATCC 19981 KIT
M. smegmatis ATCC 19420 KIT
M. szulgai ATCC 35799 KIT
M. terrae ATCC 15755 KIT
M. thermoresistibile ATCC 19527 KIT
M. triviale ATCC 23292 KIT
M. tuberculosis H37Rv ATCC 27294 KIT
M. ulcerans ATCC 19423 KIT
M. vaccae ATCC 15483 KIT
M. xenopi ATCC 19250 KIT
Nocardia brasiliense ATCC 19296 KIT
N. nova ATCC 21197 KIT
Rhodococcus equi ATCC 10146 KIT
a YUMC, Yonsei University Medical College.
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cies, such as M. fortuitum, M. celatum, M. gordonae, and M.
kansasii, that are known to contain several subtypes, each sub-
type generated distinctive restriction profiles. Therefore, the
results clearly indicated that this new PRA method could dif-
ferentiate mycobacteria at the species and even the subspecies
level.
On the basis of the above PRA results, an algorithm was
constructed (Fig. 2). In the algorithm, restriction fragments
smaller than 40 bp were omitted in order to reduce confusion
with primer-dimer bands. The different sizes of fragments were
clearly separated from each other, making interpretation of
results easier. In brief, the algorithm clearly shows that most
mycobacterial species and other related bacterial species can
be differentiated at the subspecies level by PRA using restric-
tion enzymes MspI and HaeIII. In fact, except for a few myco-
bacterial species, most of these organisms can be identified by
using a single enzyme, MspI, thus making this new method
more useful for mycobacterial species identification in the clin-
ical laboratory.
For those strains that were not differentiated by two enzyme
digestions, a third enzyme digestion was useful. For example,
even though the members of M. tuberculosis complex (M. tu-
berculosis, M. bovis, and M. africanum) were not differentiated
by using MspI and HaeIII, a third enzyme, Sau3AI, could be
used to differentiate M. africanum from other members of M.
tuberculosis complex. As another example, HincII can be used
to differentiate M. gordonae type I from M. celatum type I (Fig.
2).
The different RFLP profiles generated for the PCR products
strongly suggested to us that the rpoB region amplified by PCR
in this study has a polymorphic nature. The next question was
whether these differing RFLP profiles were species and, pos-
sibly, strain specific. If strains of a certain species also have
polymorphic RFLP profiles, the use of this method for myco-
bacterial species identification will be very complex. Therefore,
in a blinded test, clinical isolates that had been identified on
the basis of conventional tests were subjected to PRA to de-
termine their species based on the algorithm constructed dur-
ing this study. The results of this experiment clearly show that
there are no differences in the profiles of the various among
clinical isolates that belong to the same species (data not
shown). Subsequently, a substantial number of clinical isolates
that had been identified on the basis of conventional tests were
subjected to PRA. In this experiment, a total of 260 clinical
isolates were analyzed, including M. tuberculosis, M. avium, M.
intracellulare, M. fortuitum, M. chelonae, M. abscessus, M. terrae,
M. gordonae, and M. szulgai specimens (Table 2). For easy
interpretation of the PRA profiles generated by each clinical
isolate, a 50-bp ladder size marker was used as a standard size
marker and the PRA profile of M. bovis was used as an internal
size marker (Fig. 3). Results from the PRA of clinical isolates
were evaluated with the help of an algorithm generated on the
basis of PRA profiles of reference strains. Most of the PRA
results were consistent with conventional test results, while the
PRA profiles of a few strains were not present in the reference
algorithm. Based on the results of conventional tests and on
molecular biological sequence analysis, some of these strains
were determined to be M. terrae complex.
DISCUSSION
Mycobacterial identification to the species level not only is
of academic interest but also is important because it provides
a great deal of useful information on the epidemiology and
FIG. 1. Results of PRA for mycobacterial reference strains. Primer pair RPO59 and RPO39 was used. Amplified DNA was digested with MspI (A) or HaeIII (B)
restriction enzyme and run on a 4% Metaphore agarose gel. Lanes: M, DNA size marker (50-bp ladder; positions are indicated on left [in base pairs]); 1, M. gordonae
type IV; 2, M. szulgai; 3, M. kansasii type I; 4, M. gallinarum; 5, M. avium; 6, M. scrofulaceum; 7, M. asiaticum; 8, M. chelonae; 9, M. moriokaese; 10, M. phlei; 11, M.
pulveris; 12, M. fortuitum type I; 13, M. austroafricanum; 14, M. smegmatis; 15, M. marinum.
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pathogenesis of the organism, suggesting potential interven-
tion strategies, including successful treatment of patients on a
clinical basis. It is therefore important to develop methods that
are rapid and simple but yet precise and cost-effective for use
in a wide variety of clinical laboratories around the world.
Currently available methods for the differentiation of myco-
bacteria to the species level are time-consuming evaluations
based on phenotypic and biochemical tests or laborious pro-
cedures requiring expensive equipment.
The PRA technique certainly fits these requirements better
than other molecular methods. It is rapid and precise since it
employs PCR, and it is simple and cost-effective since it does
not require any expensive equipment or laborious processes
and can differentiate numerous species of mycobacteria within
a single experiment. Owing to these advantages, several PRA
methods based on different genes of mycobacteria have been
developed (2, 7, 11, 14, 25, 29, 30, 33–35, 37). However, most
of those methods require the use of more than two enzymes to
differentiate mycobacteria at the species level, as well as a
computer-assisted software program to differentiate restriction
fragments since the profiles of certain mycobacterial species
are not distinctive enough for bare-eyed interpretation.
The new PRA method developed through this investigation
has more advantages than the previous ones. As presented in
Fig. 1, it is apparent that most of the species have unique PRA
profiles. Unlike other PRA profiles, which may require com-
puter-assisted analysis and interpretation of the gels, ours does
not face problems in terms of resolution of all patterns ob-
tained during the experiments. Furthermore, problems such as
gel-to-gel variation and confusion with regard to the sizes of
the restriction fragments were limited by the use of the 50-bp
size marker and of the M. bovis PRA profile as an internal size
marker.
The restriction analysis of a 360-bp fragment within this
gene after single MspI digestion is highly effective for differ-
entiating most mycobacteria even at the species level. Only a
few species require digestion with an additional enzyme, such
as HaeIII, Sau3AI, or HincII. For some species, such as M.
gordonae, M. kansasii, M. fortuitum, and M. celatum, the dis-
crimination was even to the subtype level. For M. kansasii, this
subdivision was clearly linked to genetic divergence observed
previously by other investigators (1, 24, 27). It is therefore
possible that by using this PRA method, discrimination at the
subgroup level for other species could be similarly linked to
bacteriological and clinical specificities. Currently, we are in-
vestigating several clinical isolates, with PRA profiles distinct
from those of any of our reference strains, which also exhibit
distinctive microbiological and biochemical characteristics.
On the other hand, the four members of the M. tuberculosis
complex, which are difficult to differentiate by methods such as
sequence analysis and high-performance liquid chromatogra-
phy of mycolic acids, were also undistinguishable by our PRA
method, confirming that they are genetically similar. However,
unlike other methods, this new PRA method can further dif-
ferentiate M. africanum from the other M. tuberculosis complex
members with the added step of Sau3AI digestion. Therefore,
in cases in which a clinical isolate exhibits M. tuberculosis com-
plex profiles, PCR products can be further processed with
Sau3AI to differentiate M. africanum from other M. tubercu-
losis complex constituents. In addition, M. tuberculosis and M.
bovis can be differentiated by PCR amplification using PCR
primers derived from the esat-6 gene, which is known to be
present only in the genome of M. tuberculosis.
The fact that the species M. terrae contains strains of diverse
genotype is consistent with previous observations by other in-
vestigators (35). Currently, we are investigating the genetic
nature of these strains by sequence analysis and their pheno-
typic specificities by conventional tests. The data from these
studies will be used for establishing a new mycobacterial tax-
onomy. In this regard, PRA seems to be a very effective
method for identifying new mycobacterial species or subgroups
of mycobacteria from clinical samples.
Currently, a substantial number of mycobacterial clinical
FIG. 2. An algorithm was constructed based on the results of PRA with 40
mycobacterial reference strains and 3 other related bacterial strains. For algo-
rithm conciseness, the PRA results of 10 other mycobacterial reference strains
are not listed in this figure. TB, M. tuberculosis. The numbers indicate sizes (in
base pairs) of resulting fragments.
TABLE 2. Clinical isolates of mycobacteria subjected to species
identification by the new PRA method
Species tested No. of clinicalisolates tested
M. tuberculosis ................................................................................. 40
M. avium .......................................................................................... 40
M. intracellulare ............................................................................... 50
M. gordonae...................................................................................... 25
M. szulgai.......................................................................................... 10
M. fortuitum ..................................................................................... 25
M. chelonae ...................................................................................... 15
M. abscessus ..................................................................................... 15
M. kansasii ....................................................................................... 20
M. terrae............................................................................................ 20
Total .................................................................................................260
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isolates in our laboratory have now been identified by our new
PRA method in parallel with other reference methods, includ-
ing conventional tests and molecular biological methods such
as PRA based on the hsp65 gene and sequence analysis based
on the rpoB gene. From our experimental data it can be con-
cluded that this new PRA is a rapid, cost-effective, and efficient
method for the identification of mycobacteria in a clinical
microbiology laboratory. The whole procedure can be done in
2 days when a culture is used. Successful PRA has been
achieved with a loopful of culture taken from solid medium or
100 ml of a liquid culture such as MGIT for mycobacterial
species identification. Both of the systems work well even when
the genomic DNA is simply boiled for 5 min.
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